Nanotechnology as a Catalyst for Reintroducing Abandoned or Therapeutically Constrained Antimicrobial Agents: Opportunities and Translational Challenges.

Olowu BI, Okewale OT, Azeez AO, Adeyemi SO

Open source

DOI
10.1155/bmri/9486547
Published
2026
Container
BioMed research international
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/bmri/9486547,
  title = {Nanotechnology as a Catalyst for Reintroducing Abandoned or Therapeutically Constrained Antimicrobial Agents: Opportunities and Translational Challenges.},
  author = {Olowu BI and Okewale OT and Azeez AO and Adeyemi SO},
  year = {2026},
  journal = {BioMed research international},
  doi = {10.1155/bmri/9486547},
  url = {https://doi.org/10.1155/bmri/9486547}
}

RIS

TY  - JOUR
TI  - Nanotechnology as a Catalyst for Reintroducing Abandoned or Therapeutically Constrained Antimicrobial Agents: Opportunities and Translational Challenges.
AU  - Olowu BI
AU  - Okewale OT
AU  - Azeez AO
AU  - Adeyemi SO
PY  - 2026
JO  - BioMed research international
DO  - 10.1155/bmri/9486547
UR  - https://doi.org/10.1155/bmri/9486547
ER  - 

APA

BI, O., OT, O., AO, A., & SO, A. (2026). Nanotechnology as a Catalyst for Reintroducing Abandoned or Therapeutically Constrained Antimicrobial Agents: Opportunities and Translational Challenges.. BioMed research international. https://doi.org/10.1155/bmri/9486547

Source records